Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells. Using substances that block the activation of those pathways, they've prevented Ebola infection in cell culture experiments — potentially providing a critical early step in developing the first successful therapy for the deadly virus.
Ebola inflicts severe and often fatal hemorrhagic fever on its victims, producing 90 percent mortality rates in some outbreaks. No vaccine exists for the virus, and it is considered a high-risk agent for bioterrorism. Natural Ebola outbreaks strike periodically, often with devastating effect; recent examples include outbreaks in Uganda in 2008 and the Democratic Republic of the Congo in 2007.
The UTMB team took a new approach to stopping viral infection, using powerful new computational and analytical techniques to focus more on the host cell than the virus, according to microbiology and immunology associate professor Robert Davey.
"The premise for this work is that the virus is essentially nothing without a cell," said Davey, lead author of a paper on the research appearing this month in the journal Drug Discovery Research. "It needs to rely on many cell proteins and factors for it to replicate. The idea is that if we can suppress the expression of those cell proteins for just a short time, we can then stop the disease in its tracks."
To identify the critical proteins, the UTMB researchers — including research scientist Andrey A. Kolokoltsov, assistant professor Mohammad F. Saeed, postdoctoral fellow Alexander N. Freiberg and assistant professor Michael R. Holbrook — first conducted large-scale screening experiments using sets of cells treated with small interfering RNA (siRNA) to block 735 different genes that might produce proteins important to Ebola infection. They then added Ebola "pseudotype" viruses, artificially created virus particles made by wrapping Ebola envelope proteins around a core of genetic material from another virus. (The resulting viruses behave just like Ebola when infecting a cell, but are safe enough to work with in an ordinary lab.)
"We got a number of hits, quite a lot of places where the virus wasn't infecting the cells," Davey said. "The problem was then to understand what those hits meant."
To make sense of the data, the researchers turned to a newly developed statistical algorithm designed especially to prioritize the results of siRNA screens. After subjecting that output to further computational analysis, they found that two networks of biochemical reactions seemed particularly important to Ebola's entry into cells: The PI3 kinase pathway and the CAMK2 pathway. Since drugs to block both pathways are available, the UTMB group decided to investigate whether they would interfere with Ebola infection of cells — first using virus pseudotypes, and then, in UTMB's maximum containment BSL4 "spacesuit" lab, with Ebola Zaire itself, the variety of the virus most associated with high mortality rates.
"With the real virus in the BSL4, we found that the PI3 kinase inhibitor dropped virus titers by 65 percent, and if we used drugs which block CAMK2 function, it was just killed — stopped dead," Davey said. "This is really, very, very interesting because this pathway has a lot of potential for future pharmaceutical exploitation."
Jim Kelly | EurekAlert!
A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich
New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
20.02.2017 | Materials Sciences
20.02.2017 | Health and Medicine
20.02.2017 | Health and Medicine